Skip to content

Stryker Facial iD Universal Plate Configurator: A Retrospective Post Market Follow Up

Stryker Facial iD Universal Plate Configurator: A Retrospective Post Market Follow Up to Confirm Safety and Performance

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07245810
Acronym
UPC
Enrollment
726
Registered
2025-11-24
Start date
2024-11-18
Completion date
2026-05-31
Last updated
2026-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial Fracture, Mandibular Fractures, Maxilla Fracture, Orthognathic Surgical Procedures

Keywords

Orthognathic Surgery, Mandibular Reconstruction, Mandibular Fractures, Mandibular Reconstruction* / Methods

Brief summary

A retrospective post market follow up to confirm safety and performance of Stryker's Facial iD Universal Plate Configurator (UPC) implants in the clinical setting. The study is performed to confirm the product's performance and safety by systematically collecting clinical data on its use.

Detailed description

This is a retrospective non-interventional post-market follow up aiming at confirming safety and performance of Stryker's Facial iD UPC plating system when used in the clinical setting. This study will include patients who have previously undergone a surgical procedure involving the Study Device, with surgical outcomes evaluated retrospectively. Based on a non-inferiority study power calculation a minimum of 80 patients will be enrolled in the study. Additional patients may be enrolled up to 800 subjects depending on site enrolment rate and patient availability. Up to 3 investigational sites within the United States will participate in this study. The primary outcome parameter evaluating successful fixation or reconstruction of the midface without the need for unplanned revision surgery will be evaluated at all available follow-up timepoints of the included patients.

Interventions

DEVICEOrthognatic surgery, Reconstructive maxillofacial surgery, Mandible and maxillofacial trauma surgery

Osteotomy, Mandible and Maxillofacial reconstruction, Orthognathic surgery

Sponsors

Stryker Craniomaxillofacial
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. Patients who received a Stryker UPC plate for osteotomy, stabilization and rigid fixation of maxillofacial fractures or reconstruction as per routine clinical practice 2. Patients for whom data on the primary outcome variable is available.

Exclusion criteria

1. Patients with non-reducible and unstable fractures at the time of surgery 2. Patients with fractures of a severely atrophic mandible at the time of surgery 3. Patients with active local infections at the time of surgery 4. Patients with metal allergies and/or foreign body sensitivity at the time of surgery 5. Patients with limited blood supply or insufficient quality or quantity of bone at the time of surgery 6. Potentially non-compliant patients who are unwilling or incapable of following postoperative care instructions

Design outcomes

Primary

MeasureTime frameDescription
Successful fixation or reconstruction of the midface without the need for unplanned revision surgery.Data collected at a single time point per patient in the course of 18 months.Assessed by reviewing adverse events in patient medical charts at time point after surgery. Used to document whether an unplanned revision surgery was required or not for patients.

Secondary

MeasureTime frameDescription
Infection rateData collected at time points from patient medical charts in the course of 18 months.Determined by adverse events reported from patient medical charts.
Intraoperative complicationsData collected at a single time point per patient in the course of 18 months.Determined by adverse events reported from patient medical charts.
Postoperative complicationsData collected at time points per patient in the course of 18 months.Determined by adverse events reported from patient medical charts.
Any known adverse eventsData collected at time points per patient in the course of 18 months.Determined by adverse events reported from patient medical charts.
Plate failureData collected at time points point per patient in the course of 18 months.Determined by adverse events reported from patient medical charts.
Satisfactory occlusion achieved after additional orthodontic treatmentData collected at a single time point per patient in the course of 18 months.Data reported in patient medical charts
Time to return to solid food/normal dietData collected at a single time point per patient in the course of 18 months.Time for patient to return to solid food/normal diet post operation (dd)
Hospitalization time; ICU and normal wardData collected at a single time point per patient in the course of 18 months.Time the patient was hospitalized post procedure (dd:hh)
EuroQol-5 Domain Questionnaire (if available)Data collected at time points per patient in the course of 18 months.A descriptive system and a visual analogue scale (VAS). The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each with three to five levels of severity. The VAS provides a subjective rating of overall health on a scale from 0 to 100 (higher is better)).
Facial Appearance, Quality of Life, and Satisfaction Questionnaire (if available)Data collected at time points per patient in the course of 18 months.40 independently functioning scales and checklists. Multiple independent scales, each with a 0-100 score, where higher scores indicate better outcomes. Scores are calculated by summing responses on a 4-point Likert scale (e.g., strongly disagree to strongly agree), which are then converted to the 0-100 range. Each scale measures a specific aspect of facial appearance, quality of life, or adverse effects and cannot be summed into a single total score.
12-Item Short Form Health Survey (SF-12)Data collected at time points per patient in the course of 18 months.12 items grouped and scored to produce two separate summary scores: the Physical Component Summary (PCS-12) and the Mental Component Summary (MCS-12). The scale is transformed to a 0-100 range with higher scores indicating better health.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 23, 2026